PS

Pieter Smid

AB AbbVie: 4 patents #436 of 1,308Top 35%
AV Abb Vie: 3 patents #462 of 1,257Top 40%
Abbott: 1 patents #3,441 of 5,431Top 65%
SB Solvay Pharmaceuticals, B.V.: 1 patents #59 of 125Top 50%
📍 Weesp, NL: #40 of 254 inventorsTop 20%
Overall (All Time): #832,532 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
RE48301 Fused heterocyclic derivatives as S1P modulators Wouter I. Iwema Bakker, Hein K. A. C. Coolen, Leonardus A. J. M. Sliedregt, Maria J. P. van Dongen, Jacobus A. J. den Hartog +1 more 2020-11-10
9670220 Fused heterocyclic derivatives as S1P modulators Wouter I. Iwema Bakker, Hein K. A. C. Coolen, Leonardus A. J. M. Sliedregt, Maria J. P. van Dongen, Jacobus A. J. den Hartog +1 more 2017-06-06
9096612 Fused heterocyclic derivatives as S1P modulators Wouter I. Iwema Bakker, Hein K. A. C. Coolen, Leonardus A. J. M. Sliedregt, Maria J. P. van Dongen, Jacobus A. J. den Hartog +1 more 2015-08-04
8796262 Fused heterocyclic derivatives as S1P modulators Wouter I. Iwema Bakker, Hein K. A. C. Coolen, Leonardus A. J. M. Sliedregt, Maria J. P. van Dongen, Jacobus A. J. den Hartog +1 more 2014-08-05
8575148 Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers Michael Mlinaric, Konrad Koehler, Sara Nuñez Garcia, Elmar Wegener, Josephus H. M. Lange 2013-11-05
7371769 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites Roelof van Hes, Cornelis G. Kruse, Martinus Th. M. Tulp 2008-05-13